Clinical Trial Update: Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adding sitagliptin or pioglitazone to metformin and sulfonylurea in type 2 diabetes mellitus with insufficient glycemic control; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Januvia (sitagliptin)

Snippet

Sponsor: Sung-Chen Liu | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2012-10-10